Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies
- PMID: 16509765
- PMCID: PMC1391981
- DOI: 10.1371/journal.pmed.0030091
Five glutathione s-transferase gene variants in 23,452 cases of lung cancer and 30,397 controls: meta-analysis of 130 studies
Abstract
Background: Glutathione S-transferases (GSTs) are known to abolish or reduce the activities of intracellular enzymes that help detoxify environmental carcinogens, such as those found in tobacco smoke. It has been suggested that polymorphisms in the GST genes are risk factors for lung cancer, but a large number of studies have reported apparently conflicting results.
Methods and findings: Literature-based meta-analysis was supplemented by tabular data from investigators of all relevant studies of five GST polymorphisms (GSTM1 null, GSTT1 null, I105V, and A114V polymorphisms in the GSTP1 genes, and GSTM3 intron 6 polymorphism) available before August, 2005, with investigation of potential sources of heterogeneity. Included in the present meta-analysis were 130 studies, involving a total of 23,452 lung cancer cases and 30,397 controls. In a combined analysis, the relative risks for lung cancer of the GSTM1 null and GSTT1 null polymorphisms were 1.18 (95% confidence interval [CI]: 1.14-1.23) and 1.09 (95% CI: 1.02-1.16), respectively, but in the larger studies they were only 1.04 (95% CI: 0.95-1.14) and 0.99 (95% CI: 0.86-1.11), respectively. In addition to size of study, ethnic background was a significant source of heterogeneity among studies of the GSTM1 null genotype, with possibly weaker associations in studies of individuals of European continental ancestry. Combined analyses of studies of the 105V, 114V, and GSTM3*B variants showed no significant overall associations with lung cancer, yielding per-allele relative risks of 1.04 (95% CI: 0.99-1.09), 1.15 (95% CI: 0.95-1.39), and 1.05 (95% CI: 0.89-1.23), respectively.
Conclusions: The risk of lung cancer is not strongly associated with the I105V and A114V polymorphisms in the GSTP1 gene or with GSTM3 intron 6 polymorphism. Given the non-significant associations in the larger studies, the relevance of the weakly positive overall associations with the GSTM1 null and the GSTT1 null polymorphisms is uncertain. As lung cancer has important environmental causes, understanding any genetic contribution to it in general populations will require the conduct of particularly large and comprehensive studies.
Conflict of interest statement
Figures





Similar articles
-
Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer.Int J Cancer. 2004 Jun 10;110(2):219-24. doi: 10.1002/ijc.20075. Int J Cancer. 2004. PMID: 15069685
-
GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.Cancer Lett. 2004 May 10;208(1):65-74. doi: 10.1016/j.canlet.2004.01.002. Cancer Lett. 2004. PMID: 15105047
-
Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States).Cancer Causes Control. 1997 Jul;8(4):554-9. doi: 10.1023/a:1018434027502. Cancer Causes Control. 1997. PMID: 9242470
-
Glutathione S-transferase M1 polymorphism and the risk of lung cancer.Anticancer Res. 2003 May-Jun;23(3A):2111-24. Anticancer Res. 2003. PMID: 12894585 Review.
-
Association of glutathione S-transferase polymorphisms (GSTM1 and GSTT1) with primary open-angle glaucoma: an evidence-based meta-analysis.Gene. 2013 Sep 10;526(2):80-6. doi: 10.1016/j.gene.2013.05.032. Epub 2013 Jun 4. Gene. 2013. PMID: 23747403 Review.
Cited by
-
Significant association of glutathione S-transferase T1 null genotype with esophageal cancer risk: a meta-analysis.Mol Biol Rep. 2013 Mar;40(3):2397-403. doi: 10.1007/s11033-012-2320-6. Epub 2012 Dec 14. Mol Biol Rep. 2013. PMID: 23238916
-
Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers.Oncol Lett. 2012 Jun;3(6):1301-1306. doi: 10.3892/ol.2012.665. Epub 2012 Mar 30. Oncol Lett. 2012. PMID: 22783438 Free PMC article.
-
Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer.Cancer Detect Prev. 2009;32(5-6):403-15. doi: 10.1016/j.cdp.2009.02.004. Epub 2009 Mar 17. Cancer Detect Prev. 2009. PMID: 19282111 Free PMC article.
-
Molecular epidemiology of female lung cancer.Cancers (Basel). 2011 Apr 1;3(2):1861-76. doi: 10.3390/cancers3021861. Cancers (Basel). 2011. PMID: 24212786 Free PMC article.
-
Isozyme-specific inhibition of GSTP1-1: a crucial element in cancer-targeting drugs.RSC Med Chem. 2025 Jan 23. doi: 10.1039/d4md00872c. Online ahead of print. RSC Med Chem. 2025. PMID: 39917632 Free PMC article. Review.
References
-
- Ketterer B. Protective role of glutathione and glutathione transferases in mutagenesis and carcinogenesis. Mutat Res. 1988;202:343–361. - PubMed
-
- Kato S, Browman ED, Harrigan AM, Blomke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphism in vivo. J Natl Cancer Inst. 1995;87:902–907. - PubMed
-
- Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility . Cancer Epidemiol Biomarkers Prev. 1997;6:733–743. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous